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Correlating MRI and clinical disease 
activity in multiple sclerosis:
Relevance of hypointense lesions on short-TR/short-TE 
(Tj-weighted) spin-echo im ages
M.A.A. van Walderveen, MD; F. Barkhof, MD; O.R. Hommes, MD; C.H. Polm an, MD;
H. Tobi, MSc; S.T.F.M. Frequin, MD; and J. Valk, MD
Article abstrac t—Magnetic resonance imaging (MRI) is being used as an outcome criterion in therapeutic trials in 
multiple sclerosis (MS) on the assumption that it, as a sensitive marker of biologic disease activity, could serve as a 
surrogate marker of disability. We evaluated the relation between MRI findings and disability in a quantitative follow- 
up study of 48 MS patients. Median duration of follow-up was 24 months (range, 10 to 42 months). Computer-as sis ted 
volume measurements employing a seed-growing technique yielded a standard error of measurement of 0.275 cm2. The 
median total area of the hyperintense lesions on the initial T2-weighted images was 8.4 cm2. The median increase was
0.76 cm2/yr (9%). In a subgroup (n = 19) with short-TR/short-TE spin-echo (SE) images, we measured the hypointense 
lesion load. The median total area of the lesions at entry was 0.70 cm2, with a median increase of 0.28 cm2/yr (40%). 
The total area of the hyperintense lesions on the initial T2-weighted images showed a weak correlation with the Ex­
panded Disability Status Scale score at entry (Spearman rank correlation coefficient [SRCC] = 0.30; 0.02 < p < 0.05). 
The increase in disability showed a positive correlation (SRCC = 0.19) with the increase in hyperintense lesion load on 
the T2-weighted SE images, but thi3 correlation did not reach statistical significance (p = 0.09), probably because of 
lack of clinical progression. The number of active lesions detected by visual analysis of the T2-weighted SE images cor­
related significantly (SRCC = 0.40; 0.001 < p  < 0.01) with the number of relapses during the interval between the ini­
tial and follow-up imaging examinations. The subgroup with short-TR/short-TE SE images (whose disease was clini­
cally more active than the group as a whole) showed a significant correlation of increased disability with increase in 
hypointense lesion load (SRCC = 0.74; p  < 0.002). Our results, and those from previous follow-up studies, suggest a 
positive correlation between MRI and clinical activity, but extended follow-up studies are needed to confirm the appro­
priateness of quantitative MRI as a surrogate marker of disability in MS. Short-TR/short-TE SE images seem to be 
more relevant than T2-weighted SE images in identifying the lesions that cause disability.
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M agnetic resonance im aging (MRI) is sensitive in 
detecting  b ra in  abnorm alities in  m ultip le  sclerosis 
(MS).1 T 2-weighted spin-echo (SE) sequences are  
useful in  displaying the  overall lesion load, w here­
as  g ad o lin iu m -en h an ced  sh o rt-T R /sh o rt-T E  SE 
im ag es  id en tify  th e  c u r re n t ly  ac tiv e  le s io n s  in  
M S.2 Previous studies have show n th a t  m any  MS 
lesions are clinically silent. M R I-evident d isease 
a c t iv i ty  (new  or e n la rg in g  le s io n s  on th e  T 2- 
w eighted  SE images and enhancing  lesions on the  
sho rt-T R /sho rt-T E  SE im ages) occurs m ore f re ­
q u en tly  th a n  is detectable on clinical g rounds.3'6 
H istopathologic stud ies show th a t  abnorm alities  
seen  w ith  MRI rep resen t MS lesions.7 The m ost 
sensitive  biologic disease m easure  a t  p resen t, MRI 
is in c re a s in g ly  u sed  as an  outcom e m e a su re  in  
clinical tr ia ls  to te s t  the  efficacy of new d rugs,8 as
w as recently  i l lu s tra ted  in  th e  in te rfe ron  b e ta - lb  
tr ia l .9-10
Although the m ajority of new b ra in  MRI lesions 
are  clinically silent, the  rationale  for using  MRI as 
an  outcome criterion is th a t  th e  more MRI lesions 
develop, the  la rger the  increase in  disability  will be 
over time. However, the  correlation betw een MRI 
lesions an d  clin ical d isab ility  is n o t w ell u n d e r ­
stood. In  follow-up studies, th e  num ber, size, and  
site  of lesions have been used  to seek correla tion  
w ith  the  clinical s ta tu s  of the  patien ts. Since com­
puter-assis ted  techniques have become available, a 
more reliable and  reproducible analysis of MRI le­
sion load is now possible. M inim al changes of ind i­
vidual lesions are h a rd  to detect visually, w hereas 
co m p u te r-a ss is ted  q u a n t i ta t io n  p rov ides a m ore 
precise calculation of the  size of lesions. One cross­
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sec tio n a l s tu d y 11 show ed a  sign ifican t, a lth o u g h  
w eak, correlation betw een th e  computed lesion vol­
u m e  a n d  th e  E x p a n d e d  D isa b ili ty  S ta tu s  Scale 
(EDSS) score. A m ore recen t quan tita tive  follow-up 
s tu d y 12 show ed a s ig n if ican t correla tion  betw een 
M RI lesion load an d  EDSS score. In  th a t  study ,12 a 
S p e a rm a n  ra n k  co rre la tion  coefficient of 0.62 be­
tw een  changes in  lesion load on T2-weighted SE im ­
ages an d  EDSS score w as reported . A lthough the 
EDSS score is an  ordinal one w ith  several lim ita­
tions ,13 th e  follow-up tim e in  the  study  of Filippi et 
a l12 w as long enough (5 years) to have allowed iden­
tif ica tio n  of a  s tro n g e r  re la t io n sh ip  betw een  th e  
clinical an d  th e  M RI v a riab les  if  such a re la tion ­
ship h a d  existed.
One possible exp lanation  for th e  lack of a  closer 
re la tion  betw een MRI activ ity  and  disability is th a t  
no t all abnorm alities  seen  on T2-weighted SE im ­
a g e s  a r e  c l in ic a l ly  s ig n i f i c a n t .  I n f la m m a tio n ,  
edem a, gliosis, dem yelination, and  axonal loss are 
all r e p re s e n te d  as  a re a s  of h ig h  in te n s i ty  on T2- 
w eighted  SE im ages. Short-TR/short-TE SE images 
som etim es show a reas  of hypoin tensity  in  a  p a r t  of 
the  lesions seen on T2-weighted SE images. These 
a reas  of hy p o in ten sity  m ay  re p re se n t  th e  chronic 
MS lesion in  w hich astrocyte grow th and scarring, 
and  therefore  p e rm an en t neurologic dam age, have 
occurred14; they  m igh t be of g rea te r  clinical signifi­
cance th a n  the  to ta l lesion load seen on T2-weight- 
ed SE im ages.
We report a clinical and  MRI follow-up study  of 
48 MS patien ts . The purpose of th is  s tudy  is to de­
te rm in e  w h e th e r  a n  in c rease  in  quan tified  lesion 
load correlates w ith  a n  increase  in  disability, and  
w h e th e r such a correlation is s tronger w ith  lesions 
observed on short-TR /short-TE  SE images. By ad­
dressing  these  issues, one can evaluate  the  value of 
MRI as a  su rrogate  m a rk e r  of disability.
Methods. A cohort of 48 patients (12 men, 36 women) 
was followed clinically and with MRI. The patients were 
classified at point of entry into the study. The cohort 
consisted of 32 patients with clinically definite MS, 13 
with laboratory-supported definite MS, and three with 
clinically probable MS.15 The mean age was 33.2 years 
(range, 21 to 62 years), and the median disease duration 
was 4.0 years (mean, 5.4 years; range, 0 to 25 years). 
Thirty-three patients had relapsing-remitting MS and 
15 had chronic progressive MS (one primary progres­
sive, 14 secondary progressive). The EDSS score16 was 
estimated shortly before or after the MRI examination 
by a neurologist blinded to the MRI analysis. Baseline 
EDSS score was estimated on the basis of frequent prior 
EDSS scores for patients who suffered from a relapse at 
the time of imaging. (A relapse was defined as any clini­
cal deterioration lasting more than 24 hours tha t was 
not related to a concurrent disease.) The number of re­
lapses between the first and the second MRI examina­
tions was documented. The median duration of follow-up 
was 24 months (range, 10 to 42 months). Patients were 
treated only with short courses of intravenous methyl- 
prednisolone when indicated; no other immunosuppres­
sive therapy was given.
Imaging was performed on a 0-6-T machine (Techni-
care, Solon, OH) with a standard headcoil. The same 
imaging protocol3 was used for the first and the second 
MRI examinations. Identical slice repositioning was 
achieved by means of unenhanced images in two or three 
consecutive planes, thereby correcting for differences in 
the patient’s position according to internal landmarks 
(angulation along the line connecting the caudal border 
of the pituitary gland and the fastigium of the fourth 
ventricle; the Z center was aligned with the caudal bor­
der of the splenium of the corpus callosum). From the 
logical midsagittal image, double oblique two-dimen­
sional axial series were planned. T2-weighted SE images 
were obtained with 2,755/60,120/2 (TR/TE/excitations). 
Nineteen slices with an in-plane resolution of 1,0 X 1.3 
mm and a slice thickness of 5 mm were obtained with a 
gap of 1.25 mm, resulting in a Z range of 11.75 cm. Nine­
teen patients received contrast-enhanced short-TR/short- 
TE SE images on both occasions. Gadopentetate dimeg- 
lumine (Magnevist, Schering AG, Berlin) was adminis­
tered intravenously as a bolus in a dose of 0.2 mmol/kg. 
Short-TR/short-TE SE images (two series of nine slices) 
were obtained with 450/28/4, starting 5 to 10 minutes 
after gadolinium injection.
The images were analyzed by observers blinded to the 
clinical data, using visual inspection and computer- 
assisted techniques; for both techniques, the intra-ob­
server variability (precision) was assessed in five pa­
tients. As the follow-up images were analyzed shortly 
after one another, the images used for the intra-observer 
variability were also analyzed in a short time interval. 
On visual inspection, the number of new or enlarging le­
sions on the follow-up (T2-weighted) image (compared 
with the initial image) was assessed as a measure of MRI 
activity by two experienced readers in conference. The 
short-TR/short-TE SE images were not analyzed visu­
ally. Computer-assisted volume measurements were per­
formed by a single observer on Sparc-2 and -10 worksta­
tions (Sun, Palo Alto, CA) using home-developed soft­
ware. On the long-TR (T2-weighted) SE images, the sur­
faces of the hyperintense lesions were measured in com­
parison with the surrounding white matter (figure 1A), 
On the short-TR/short-TE SE images, obtained after ad­
ministration of gadopentetate dimeglumine, we mea­
sured the surfaces of the hypointense lesions (figure IB) 
and the surfaces of lesions that showed enhancement. A 
hypointense lesion was defined as any region visible on 
the short-TR/short-TE SE images corresponding to a re­
gion of high signal intensity on the T2-weighted images, 
with low signal intensity relative to the surrounding 
white matter. We mainly used a seed-growing method for 
calculating the surfaces of the lesions: after a seed point 
is positioned in a part of the lesion, the boundaries of 
this region are grown toward interactively set threshold 
intensities (figure 1, C and D). Once the thresholds have 
been established for the first lesion, these can usually be 
applied to the other lesions, thus speeding up the rou­
tine. If no satisfactory definition of subsequent lesions is 
obtained, the threshold levels can be adapted for each le­
sion. When this technique failed (eg, due to low contrast 
between the lesion and the surrounding tissue), a man­
ual tracing technique was used (infrequently). Once the 
boundaries of the lesions had been established, the sur­
face of the lesions was calculated per slice (figure 1, E 
and F). A distinction was made between supratentorial 
and infratentorial (cerebellum, mesencephalon, medulla 
oblongata, and pons) lesions. By multiplying the surfaces 
by the interslice distance (0.625 cm), it is possible to ob­
tain an estimate of the actual volumes of the lesions.
September 1995 NEUROLOGY 45 1685
S66T . l a q u é e l a s  S t  A O O l O H f i a N  9 8 9 1
u m
o U i a n i B J B d a o a  S m s n  S t i ^ s a *  p a p i s - O A j  ^ A u e p n n  s u o s i
s u o i ^ p a a o o  a q v  J O |  p a i B p o p o  s b m  ( q o H S )
j l j B t t i  j q i  p a j j o o  ^  a o u B o y r a S i s  b  ‘s r ç s ^  j o j  p o s n  9 j b
a t L I  ' u o y i d u o s s p
‘p e ^ n q u ^ s i p  Á j j B t H
m * j o u  } o u  0 J 0 M  B ^ B p  0 q ^  j o  j s o r a  s y  c I C I M S  \ b o
m * T ^ S t t ^ S S B M . S IS /C lB U B  I B O I Î S I Î B ^ S
m w m m m
■ ' ( d
p a v e s i )  d O í ¡ & ¿ ? d ' è u n o f t i O D .  d t [ t  i i i i f t i m
( p 3 t { P W y }  9 0 ^ u n e -  wq% B u u n s v d i u  6 q
■ 0 f P i m 2 V d - ü ß t y i $ t  s d u v p i m o q  p a u r j
-ino ay i  u iy iicn  suoisaj ay} Jo vauv
m l J j  Y d  V U1°  O )  s m i i s i t d i i n  p ¡ o i [ S d J X $
las Xjdapovuatm p jvm o} umouS auv
i t o & B j  s i l f i  j o  s a u v p u n o q  d t¿ $  m t ß  
p u t )  ‘t i o j s d j  d y í  j - o  i j v d  ¡ v o i d f y  o
i n  p d n o i p s o d  s i  :?m o d  p a d s  v  u o i s d j  
y o m  j o j  ( f r )  d S v i m  q r&  n  j - i i o m
■ f U J j ~ l d 0 li s  d l i ß ■u o  s ú o is & i 3 § u d % m
- o d i î i [  s t )  j. D d d d v  ( ÿ )  d è t ) u n  
patygpcn-zj, ay} uo suoisaj K}isuajm  
-yä ty  ay} Jo amos )v V  3}0N  vCpm s  
ay} m  s}ua i}vd  ay} Jo avo Jo saSviui
3 S I U l - u o y s  p u v  (3 g)
oyaa-mds pa iyS pm -S j 7  a m ä u
■ 1
*Y
& W s f <
* r :;'SÉ
< & & & ■ ' m
, \ - l ‘ >v.
W . o / l i
¡Umm
I
' t t
K . !
%
'y  y V/i r- V
" '  "  (>/ ' ; î ; . '  ‘ r ^ W v  • "• • " / -
• ' / x
S . ' à  f i . K  
•• ••• % ,
!% <-' ■■■■ ■■ ■•' ■v / '
Si' /À».'
# '
v‘- » ^
iv/<-
, #
/ .
/ /  ' ' '
■ii
v .
; V . :
■ W W Æ w - y  ' ' V *  /'• /'• ^ ;•••• ' ' # ï .
. î .
v - r
*"■"■■■■■■ % - Â > v
:)d
, c > .
V
I /'i
' Í ; • v .  '
■ x 'i l ié lp l i i
:;:-iis t^lwliiliÉS’
# - p P
4 Æ : ; ,
\> lM  ?■■'■' '<< i
e t ' .
■//'
....... .
...............
W -, X'-O,-v-'a/•<.'• •^'-. v- '/ 'o x -.' ': . • ■%*■'■,/.■ ''«■'■■ <■
, . / / - y /
* ;C , if
' X
^  ^  ' - ^  ''A  < r  ’ '
:m mm m
. . ■.. >// >■ v/s.^ "?- ' |>/ v '- y -/ ■.
M vV/ 0 /c
/iJ
% 0 é .
y  ■
w 
' ' 1 ^ ;
V  > i .  : - V -
■ ' '  '""< J> .W r m p ,
. / / ,
<•
' - X . '
v % . '•! '•/ .
. ^ ' a
• /
»
^ 1 1
*
■>/:
â - 'x c :
.>!
•'/•'v  ■r'.
' X' ' 1/ X
'  ■ ■ ■ ■ 'if*-. , ■
. . . . . .
vl^ fíí^ WV * .  yÆ  > / •-/•' %  f  
■ : Ä/: #  
f y ' f r t - . .  V'■Vi
-?■' i(î * : r ;
■Ss y ^ ^ J y y - y ^ 'V - :<
&
x yyfx:<%. '•>.
'4 % È ? ÿ /s  •■%''■'■■ 
y y  '^ i i r y y w - . .
w >.
^ f ' - ^
&
y/--/-ry / ■ s>.
\
www« g gna wwiyMjbæi m>î  yw » w  ¿jw*wo»aw#igjngfg wrt »CTwüfcgAwnieiaMu J-ww ^ ¡j i M >■ Wffjjftftwtotfiau u »! < ; i  ü t  en i  i tiu  wi^ ìwb»w »u nti»  »ji w^nw mne a w ttBt r w  r  ^jwbjjohuui en < m w >; > ¿aw
Table. Intraobserver variation for computer-assisted measurement (brain area in cm2) and for visual 
analysis (number of new or enlarging lesions on the T2-weighted images)
Pt 1 Pt 2 Pt 3 Pt 4 Pt 5 Meai
T2-weighted images
Observation 1 9.43 6.26 31.44 45.69 30.34 24.63
Observation 2 9.00 5.88 30.63 44.36 29.79 23.93
Difference 0.43 0.38 0.81 1.33 0.55 0.70
Percentage difference 4.5 6.1 2.6 2.9 1.8 3.58*
Short-TR/short-TE SE images
Observation 1 0.68 0.70 10.37 6.88 17.67 7.26
Observation 2 0.61 0.72 9.90 6.31 17.32 6.97
Difference 0.07 0.02 0.47 0.57 0.35 0.29
Percentage difference 10.3 2.9 4.5 8.3 2.0 5.6*
Visual analysis
Observation 1 5 2 21 8 4 8
Observation 2 5 2 35 14 3 12
Difference 0 0 14 6 1 4
Percentage difference 0 0 67 75 25 33:i:
Difference -  observation 1 m inus observation 2 , Absolute values are given. Percentage difference = difference/observation 1 for each of the 
patients.
!|! Mean percentage difference = sum of the percentage differences of the 5 patients/number of patients.
R e s u l t s .  The m ed ian  ED SS score w as 2.0 (mean, 
2.2) a t  th e  tim e of the  in itia l scan and 2.0 (mean, 
2.5) a t  th e  tim e of the  second scan. Forty-one p a ­
t ie n ts  show ed an  in c rease  in  E D SS score of less 
th a n  one full p o in t d u r in g  th e  follow-up period; 
seven p a tien ts  showed an  increase in  EDSS score 
equal to or g rea te r  th a n  one full point during  fol­
low-up. (Forty-six p a tie n ts  showed an  increase in 
EDSS score of less th a n  one full point a  year; two 
p a tien ts  showed an  increase  in  ED SS score equal 
to or g rea te r  th a n  one full point a  year.) A lthough 
the  in c rease  in  d isab ility  w as significantly  la rg e r  
th a n  zero (Wilcoxon signed ra n k  te s t, p  = 0.003), 
the  progression in  th is  group w as sm all in clinical 
te rm s . T h e  m e d ia n  n u m b e r  of re la p se s  w as 2.0 
(range, 0 to 6) during  th e  in te rval betw een the  first 
and second MRI exam inations (mean, 2.1).
I t  typically  took 30 to 45 m in u tes  to analyze a 
se t of T 2-w eig h ted  SE im ag es  (19 slices p e r  p a ­
tien t) , d ep en d in g  on th e  e x te n t  of ab n o rm alitie s  
p resen t and  the  experience of the  observer. For the  
sho rt-T R /sho rt-T E  SE im ages, ab o u t 30 m in u te s  
are  needed, th e  com parison w ith  th e  T2-w eighted 
im ages being the  tim e-consum ing factor. The s ta n ­
dard  e rro r  of m easu rem en t w as 0.275 cm2 for the  
T2-weighted im ages. In  general, th e  in tra-observer 
varia tion  seem s dependen t on the  ex ten t of the  ab­
norm alities (table), being sm aller for the  la rger le­
s io n  lo a d s  p r e s e n t  on th e  T 2-w e ig h te d  im a g e s  
(3.6%) th a n  for the  m arked ly  sm aller lesion loads 
on th e  sh o rt-T R /sh o rt-T E  SE  im ag es  (5.6%). By 
contrast, th e  in tra-observer va ria tion  of the  visual 
analysis (table) w as m ore m arked  in  cases w ith  a 
high n um ber of active lesions.
T h e  m e d ia n  n u m b e r  of n ew  le s io n s  w as  4 .0  
(ran g e , 0 to 52), a n d  th e  m e d ia n  n u m b e r  of e n ­
la rged  lesions w as 0.0 (range, 0 to 17). A m edian
total of 4.5 active lesions (range, 0 to 69) w as seen 
on th e  second im age. The 48 p a t ie n ts  in i t ia l ly  
showed a median total lesion load of 8.4 cm2 (range, 
0.6 to 73.4) and a median total lesion volume of 5.3 
cm3. On the  follow-up image, the m edian to ta l le­
sion load had  increased to 11.4 cm2 (range, 1.5 to 
91.6) and the median total lesion volume to 7.1 cm3. 
T he  y e a r ly  in c re a se  in  to ta l  les ion  load  on T2- 
weighted images ranged from —1.9 to 9.3 cm2, w ith  
a m edian of 0.76 cm2 (9%), which was highly signif­
icant (Wilcoxon signed ran k  test, jd < 0.00001).
We m easured hypointense lesions on the  short- 
T R /short-T E  SE im ages in  the  19 p a t ie n ts  w ith  
such images. We calculated an in itia l m edian  le­
sion load of 0.70 cm2 (range, 0 to 18.2) and  a  m e­
dian  lesion volume of 0.44 cm3 on the in itia l image. 
At follow-up, the  m edian lesion load was 1.3 cm2 
(range, 0 to 24.8) and the m edian lesion volume 0.6 
cm 3. T he a n n u a l increase  in  h y p o in ten se  lesion  
load ranged from -0 .7  to 3.3 cm2, w ith  a  m edian of 
0.28 cm2 (40%), which was statistically  significant 
(Wilcoxon signed ran k  test, p  = 0.01).
EDSS score a t the time of the  first image corre­
la ted  weakly w ith the  m easured  lesion volume on
the T2-weighted SE (SRCC = 0.30; 0.02 < p  < 0.05) 
b u t not on the  short-TE/short-TR images. The dis­
ease duration correlated only weakly (SRCC = 0.30; 
p  = 0.04) w ith the  computed in itia l supraten toria l 
lesion volumes on the  T2-weighted SE images. The 
n um ber of active lesions co rre la ted  significantly  
w ith  the  num ber of relapses (SRCC = 0.40; 0,001 < 
p  < 0.01) bu t not w ith  th e  difference in EDSS score 
over the in terval period (SRCC = 0.18; p  > 0.1). We 
then  divided the pa tien ts  into an  MRI active group 
(num ber of active lesions > 0) and an MRI stable 
group (number of active lesions = 0), but we did not 
find a significant difference in  increase in disability
September 1995 NEUROLOGY 45 1687
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Figure 2. Relation between the change in lesion load on 
the T2-weighted images and the change in EDSS score in 
48 patients.
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Figure 3. Relation between the change in hypointense 
lesion load on Tr weighted images and the change in 
EDSS score in a subgroup of 19 patients.
(Mann-Whitney U test, p = 0.61).
For the T2-weighted SE images, the increase in 
EDSS score correlated positively, but not signifi­
cantly, with any measured lesion volume (supra- 
tentorially, SRCC = 0.19; infratentorially, SRCC =
0.21). The relation between the increase in EDSS 
score and the increase in total lesion load on T2- 
weighted images is shown in figure 2 (SRCC = 0.19; 
NS). The correlation between T2 lesion load and 
disability did not differ between patients with a re- 
lapsing-remitting disease course and those with a 
secondary progressive form of MS. The number of 
relapses during the follow-up period did not corre­
late significantly with the increase in T2 lesion load
(SRCC = 0.22; NS).
For the short-TR/short-TE SE images, the differ­
ence in EDSS score between the first and second 
images showed a strong correlation (SRCC = 0.74; 
p < 0.002) with the increase in hypointense lesion 
load (figure 3). For the subgroup of 19 patients 
with these images, we checked the correlation coef­
ficient between the increase in EDSS score and the 
increase in lesion load on the T2-weighted SE im­
ages; it was higher (SRCC = 0.34), but not signifi­
cantly (0.1 < p  < 0.2), than the correlation coeffi­
cient for the whole group (SRCC = 0.19), illustrat­
ing that the subgroup was biased toward more ac­
tive disease. The increase in hypointense lesion 
load did not correlate with the number of relapses 
in the follow-up period (SRCC = —0.29; NS).
To establish the predictive value of lesion load at 
entry, we correlated the initial lesion load with 
changes in lesion load and disability at follow-up. 
The initial lesion load on T2-weighted images corre­
lated (SRCC = 0.48; p  < 0.001), as expected, with 
the increase in lesion load (figure 4) and also corre­
lated with the increase in EDSS score (SRCC =
0.38; 0.001 < p  < 0.01). The increase in EDSS score 
correlated only weakly with the measured hypo­
intense lesion load on the initial short-TR/short-TE 
SE images (SRCC = 0.42; 0.05 < p < 0.1); the initial
Figure 4. Relation between the initial lesion load on the 
T2-weighted images and the change in lesion load at 
follow-up in 48 patients.
lesion load correlated weakly (SRCC = 0,41; 0.05 < 
p  < 0.1) with the increase in lesion load of these le­
sions.
Discussion. The increase in MRI lesion load, mea­
sured on the T2-weighted images, correlated 
weakly, but not significantly, with the increase in 
disability as measured by EDSS score (figure 2). 
Filippi et al found a correlation coefficient of 0.62 
between lesion load on T2-weighted images and 
EDSS score in their follow-up study in patients 
with clinically isolated syndromes suggestive of 
MS,12 which supports the use of MRI as a surrogate 
marker of disability in treatment trials. That we 
did not detect a relation is probably related to our 
follow-up period being relatively short and to the 
group of MS patients we studied being relatively 
stable clinically (only seven patients showed an in­
crease in EDSS score equal to or greater than one 
full point during follow-up). Although one might ex­
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pect a  correla tion  w ith  th e  in lra ten to ria l region,17 
th e  in c rease  in  in f ra te n to r ia l  lesion load did not 
c o rre la te  w ith  th e  in c rease  in  ED SS score. This 
could  be  d u e  to  th e  d iff icu lty  in  m e a s u r in g  in ­
fra ten to ria l lesion volumes: the  lesions in this a rea  
are  very sm all, th e re  are  d isturbing flow artifacts 
from th e  th ird  and  fourth  ventricles, and there  is 
re la tiv e ly  poor c o n tra s t  of these  lesions (perhaps 
due to th e  cerebellum  not being in the  center of the 
coil). A n o th e r  p o ss ib le  e x p la n a t io n  is  t h a t  th e  
EDSS score m ain ly  rep resen ts  spinal disease activ­
ity, a lthough  p re lim inary  resu lts  from spinal im ag­
ing stud ies also do not explain changes in disability 
(Dr. A.J. Thom pson, personal communication).
We found th a t  M RI lesion load a t  en try  predicts 
th e  increase in  disability  an d  the  increase in  lesion 
load a t  follow-up. T h is  is in  ag reem en t w ith  th e  
s tudy  of F ilippi e t a l,12 w hich found th a t  MRI lesion 
load a t  p resen ta tio n  in  pa tien ts  w ith  clinically iso­
la ted  syndrom es is a  s trong  predictor of the  degree 
of d isability  an d  th e  increase in  lesion load 5 years 
la ter. W hen MRI is used  as a selection criterion for 
t re a tm e n t  tr ia ls , p a tien ts  w ith  a h igh  in itia l lesion 
load are  more likely to develop progressive disabil­
ity  (figure 4).
In tra-observer variab ility  for q uan tita tion  is de­
penden t on th e  ex ten t of abnorm alities p resen t on 
the im ages (table), being lower (ie, q uan tita tion  is 
more accurate) in  cases of extended abnorm alities 
(in w hich it  is difficult to analyze differences in  size 
v isually  an d  in  which the  in tra-observer variab ility  
for th e  v isual analysis is high), as in  pa tien ts  w ith  
secondary progressive disease.5 The in tra-observer 
v a r ia t io n  for lesion  q u a n t i ta t io n  falls  w ell below 
the  m edian  increase  per year. This k ind of q u an ti­
ta t io n  seem s to  be a n  a p p ro p r ia te  an d  objective 
m ethod by w hich to evaluate  MRI lesion load and  
MRI d isease  ac tiv ity  over a  long period (ie, m ore 
th a n  1 year). V isual analysis of MRIs could be more 
useful for m onitoring  disease activity in  short-term  
s tu d ie s  ( le ss  t h a n  6 m o n th s ) ,  e sp e c ia l ly  w h e n  
m onthly  gadolin ium -enhanced im ages are  used .18-19
In  a g re e m e n t  w ith  th e  q u a n t i ta t iv e  m e a s u re ­
m ent, th e re  w as no re la tion  between the  num ber of 
active lesions (new or enlarging) on v isual analysis 
and  the  increase in  EDSS score in the  in terval be­
tw e e n  im a g in g  e x a m in a tio n s , a lth o u g h  th is  h a s  
been rep o rted  in  o th e r  s tu d ie s .20*21 This m igh t be 
due to th e  difficulty in  analyzing differences in size, 
especially w hen the  lesion load is h igh and conflu­
en t lesions a re  p re sen t. Also, we did no t analyze 
th e  n u m b er of lesions sh rink ing  or “d isappearing” 
(beyond th e  scanner resolution). The num ber of ac­
tive (new or enlarging) lesions did, however, corre­
la te  s ign ifican tly  w ith  th e  n u m b er of re lapses  in 
th e  in te rv a l period. U sually , sequen tia l (monthly) 
con trast-enhanced  MRI is used to m onitor disease 
activity in  MS, especially to evaluate  tre a tm e n t ef­
fects in  sh o rt- te rm  (phase II) studies. O ur resu lts  
show  t h a t  ac tive  le s io n s  on T 2-w eigh ted  im ages 
m ig h t a lso  be u se fu l as an  outcom e m e a su re  in  
phase  III s tud ies over longer periods (and in la rger
sam ples), in  w hich  i t  is d ifficult to perfo rm  f re ­
quent (monthly) imaging.
The m ost salien t finding in our follow-up study  
is the  strong correlation between the difference in 
EDSS score an d  th e  h y p o in ten se  lesion  load on 
short-T R /short-T E  SE im ages (figure 3). The le ­
sions visible on the T2~weighted SE images rep re ­
sent both active and inactive MS plaques, and i t  is 
not possible to differentiate between early  lesions 
(edem a, in flam m atio n , an d  m ild  dem yelina tion ) 
and chronic lesions (severe dem yelination, axonal 
loss, and gliosis). Some MS lesions visible on T2- 
weighted SE images can also been seen on short- 
TR/short-TE SE images as regions w ith  hypointen- 
sity and a more or less distinct boundary. Little is 
know n abou t th e  va lue  of th e se  h y p o in ten se  le ­
sions. One s tu d y  u n d e r l in e s  th e  im p o r ta n c e  of 
these  lesions in  d iffe ren tia ting  be tw een  MS a n d  
subcortical arteriosclerotic encephalopathy (SAE); 
hypointense lesions on the  short-TR/short-TE SE 
images are uncommon in  SAE, even though high- 
signal lesions are  visible on T2-w eighted  SE im ­
ages.14 SAE lesions m ainly  rep resen t m ild  dem y­
e lina tion  b u t  l i t t le  gliosis or axonal loss. H ypo­
in tense  lesions on short-T R /short-T E  SE im ages 
may represent chronic MS plaques, in which a s tro ­
cyte growth and scarring appear.14
W hat then  causes the low signal on these  short- 
TR/short-TE SE images? I t  could be due to changes 
in Tx relaxation  time or to changes in  o ther MRI 
variables. B arnes et a l22-23 showed th a t  p ro longa­
tion of T 1 relaxation time is p resen t in  experim en­
ta l gliosis, in  contrast to edema, w here prolonga­
tion of T2 relaxation time is almost twice th a t  of T 1 
re la x a t io n  tim e. H ieh le  e t a l24 a n a ly z e d  u n e n ­
hanced  Tj-weighted im ages of MS p a tie n ts  w ith  
magnetic transfer imaging (MTI). They divided th e  
MS lesions visible on th e  T2-weighted SE im ages 
into either isointense or hypointense lesions visible 
on the ^ -w e ig h ted  images. The MTI ra tio  of th e  
hypointense lesions appeared  to be decreased  in  
com parison  w ith  th a t  of th e  iso in te n se  le s io n s . 
H ie h le  e t  a l co n c lu d ed  t h a t  t h e  h y p o in te n s e  
p laq u es  re p re se n te d  th e  m ost d e m y e lin a te d  le ­
sions. In  hypo in tense  sh o rt-T R /sh o rt-T E  SE l e ­
sions, perm anent neurologic dam age has probably 
occurred, and  such lesions m ay  co rre la te  b e t te r  
w ith clinical disability th a n  do T2-weighted SE le­
sions. Indeed, a recent s tudy25 showed an  inverse 
correlation of average MTI ratio  w ith  EDSS score 
(SRCC = -0 .4 4 ), th is  co rre la tion  being s tro n g e r  
th an  th a t  between to tal lesion area  on T2-weighted 
images and EDSS score (SRCC = 0.33).
In  conclusion, com pu ter-ass is ted  volum e m ea­
surem ent can be useful in  m onitoring disease activ­
ity  in  MS. The in tra -observer variab ility  for th is  
m ethod  is sm all com pared  w ith  t h a t  for v isu a l  
analysis of MRIs. We showed th a t  an  increase in  
MRI lesion load correlates positively w ith  an  in ­
crease in disability, while the  num ber of active le­
sions correlated significantly  w ith  the  num ber of 
relapses. E xtended  follow-up stud ies w ith  la rg e r
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samples over longer periods (in patients with 
greater increase in disability) are needed to assess 
the definite role of quantitative MRI as a surrogate 
marker of disability in MS treatment trials. Short- 
TR/short-TE SE images seem to be more specific 
than T2~weighted SE images in identifying the le­
sions that cause disability.
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